Scholarlink

<p>Plasmids remain by far the most common medium for delivering engineered DNA to microorganisms. However, the reliance on natural plasmid replication mechanisms limits their tunability, compatibility, and modularity. Here we refactored the natural pMB1 origin and created plasmids with customizable copy numbers by tuning refactored components. We then created compatible origins that use synthetic RNA regulators to implement independent copy control. We further demonstrated that the synthetic origin of replication (SynORI) can be engineered modularly to respond to various signals, allowing for multiplexed copy-based reporting of environmental signals. Lastly, a library of 6 compatible SynORI plasmids was created and co-maintained in <i>E. coli</i> for a week. This work establishes the feasibility of creating plasmids with SynORI that can serve as a biotechnology for synthetic biology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Engineering plasmids with synthetic origins of replication

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月2日

查看全文
  • Baiyang Liu,
  • Zhi Ren Darren Seet,
  • Xiao Peng,
  • Matthew R. Bennett,
  • Matthew R. Lakin,
  • James Chappell

摘要

Plasmids remain by far the most common medium for delivering engineered DNA to microorganisms. However, the reliance on natural plasmid replication mechanisms limits their tunability, compatibility, and modularity. Here we refactored the natural pMB1 origin and created plasmids with customizable copy numbers by tuning refactored components. We then created compatible origins that use synthetic RNA regulators to implement independent copy control. We further demonstrated that the synthetic origin of replication (SynORI) can be engineered modularly to respond to various signals, allowing for multiplexed copy-based reporting of environmental signals. Lastly, a library of 6 compatible SynORI plasmids was created and co-maintained in E. coli for a week. This work establishes the feasibility of creating plasmids with SynORI that can serve as a biotechnology for synthetic biology.